Lakefront Biotherapeutics NV's revenue has grown 66% a year over three years, and grown 18% a year over five. Revenue growth, 3-year annual rate: +66% (Biotechnology median +21%). Revenue growth, 5-year rate: +18%, growth has picked up over the last three years. Years of annual history on file: 11, FY2015 to FY2025, as filed.

LKFTLakefront Biotherapeutics NV

Healthcare

$31.64-7.2% 1Y

$31.64

$26.0752 weeks$34.64

Is it growing?

Good

Operating margin widening (+79.3 points). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data

Margin direction+79.3 points operatingSEC EDGAR · Jun 30, 2021

Trailing-twelve-month operating margin, -39.0% now against -118.3% a year earlier.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is LKFT growing?

Lakefront Biotherapeutics NV's revenue has grown 66% a year over three years, and grown 18% a year over five.

+66%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +18%
Revenue growth, 5-year rate · +66% over three · growth has picked up over the last three years
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›